Jaguar Animal Health Inc
Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. The company operates through two segments, Animal Health and Human Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products. T… Read more
Jaguar Animal Health Inc (JAGX) - Net Assets
Latest net assets as of September 2025: $4.36 Million USD
Based on the latest financial reports, Jaguar Animal Health Inc (JAGX) has net assets worth $4.36 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($49.47 Million) and total liabilities ($45.11 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $4.36 Million |
| % of Total Assets | 8.81% |
| Annual Growth Rate | 1.09% |
| 5-Year Change | -62.25% |
| 10-Year Change | 47.62% |
| Growth Volatility | 133.03 |
Jaguar Animal Health Inc - Net Assets Trend (2007–2024)
This chart illustrates how Jaguar Animal Health Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Jaguar Animal Health Inc (2007–2024)
The table below shows the annual net assets of Jaguar Animal Health Inc from 2007 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $6.49 Million | +32.61% |
| 2023-12-31 | $4.90 Million | +461.14% |
| 2022-12-31 | $-1.36 Million | -111.44% |
| 2021-12-31 | $11.85 Million | -31.10% |
| 2020-12-31 | $17.20 Million | +61.17% |
| 2019-12-31 | $10.67 Million | +98.27% |
| 2018-12-31 | $5.38 Million | -68.81% |
| 2017-12-31 | $17.26 Million | +803.33% |
| 2016-12-31 | $-2.45 Million | -155.79% |
| 2015-12-31 | $4.40 Million | +301.29% |
| 2014-12-31 | $1.10 Million | +352.09% |
| 2013-12-31 | $-434.85K | -108.05% |
| 2007-12-31 | $5.40 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Jaguar Animal Health Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 29740284900.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Comprehensive Income | $-467.00K | -6.41% |
| Other Components | $354.23 Million | 4862.51% |
| Total Equity | $7.29 Million | 100.00% |
Jaguar Animal Health Inc Competitors by Market Cap
The table below lists competitors of Jaguar Animal Health Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Shemen Industries Ltd
TA:SMNIN
|
$1.26 Million |
|
Sierra Grande Minerals Inc
OTCQB:SIERF
|
$1.26 Million |
|
IDH DEVELOPMENT S.A.
F:7E2
|
$1.26 Million |
|
Hexagon Energy Materials Limited
F:F93
|
$1.26 Million |
|
DAVITA HLTH CARE - Dusseldorf Stock Exchang
DU:TRL
|
$1.26 Million |
|
STRIP TINNING HLDG.LS-01
F:VH3
|
$1.26 Million |
|
COACH - Dusseldorf Stock Exchang
DU:COY
|
$1.26 Million |
|
AbleGroup Bhd
KLSE:7086
|
$1.26 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Jaguar Animal Health Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 4,961,000 to 7,285,000, a change of 2,324,000 (46.8%).
- Net loss of 38,492,000 reduced equity.
- New share issuances of 31,910,000 increased equity.
- Other comprehensive income increased equity by 185,000.
- Other factors increased equity by 8,721,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-38.49 Million | -528.37% |
| Share Issuances | $31.91 Million | +438.02% |
| Other Comprehensive Income | $185.00K | +2.54% |
| Other Changes | $8.72 Million | +119.71% |
| Total Change | $- | 46.85% |
Book Value vs Market Value Analysis
This analysis compares Jaguar Animal Health Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.02x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-12-31 | $0.00 | $0.48 | x |
| 2015-12-31 | $0.00 | $0.48 | x |
| 2016-12-31 | $0.00 | $0.48 | x |
| 2017-12-31 | $0.00 | $0.48 | x |
| 2018-12-31 | $0.00 | $0.48 | x |
| 2019-12-31 | $152471428.57 | $0.48 | x |
| 2020-12-31 | $33729411.76 | $0.48 | x |
| 2021-12-31 | $2186629.00 | $0.48 | x |
| 2022-12-31 | $-56201.88 | $0.48 | x |
| 2023-12-31 | $321.70 | $0.48 | x |
| 2024-12-31 | $24.73 | $0.48 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Jaguar Animal Health Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -528.37%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -329.30%
- • Asset Turnover: 0.22x
- • Equity Multiplier: 7.33x
- Recent ROE (-528.37%) is below the historical average (-354.30%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2007 | 0.00% | -8416.39% | 0.03x | 0.00x | $-25.38 Million |
| 2014 | -785.38% | 0.00% | 0.00x | 5.25x | $-8.72 Million |
| 2015 | -370.34% | -6305.24% | 0.02x | 2.82x | $-16.73 Million |
| 2016 | 0.00% | -10410.87% | 0.04x | 0.00x | $-14.49 Million |
| 2017 | -127.27% | -503.73% | 0.10x | 2.53x | $-23.69 Million |
| 2018 | -597.16% | -727.92% | 0.11x | 7.62x | $-32.68 Million |
| 2019 | -361.09% | -667.34% | 0.16x | 3.41x | $-39.61 Million |
| 2020 | -196.54% | -360.25% | 0.22x | 2.49x | $-35.53 Million |
| 2021 | -452.98% | -1213.26% | 0.08x | 4.59x | $-53.76 Million |
| 2022 | 0.00% | -396.91% | 0.25x | 0.00x | $-47.39 Million |
| 2023 | -832.49% | -423.11% | 0.19x | 10.23x | $-41.80 Million |
| 2024 | -528.37% | -329.30% | 0.22x | 7.33x | $-39.22 Million |
Industry Comparison
This section compares Jaguar Animal Health Inc's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $59,082,939
- Average return on equity (ROE) among peers: -341.19%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Jaguar Animal Health Inc (JAGX) | $4.36 Million | 0.00% | 10.35x | $1.26 Million |
| Aadi Bioscience Inc (AADI) | $-124.24K | 0.00% | 0.00x | $17.03 Million |
| America Great Health (AAGH) | $-992.37K | 0.00% | 0.00x | $2.12 Million |
| Ascentage Pharma Group International (AAPG) | $70.63 Million | -1310.51% | 34.40x | $2.25 Billion |
| Aardvark Therapeutics, Inc. Common Stock (AARD) | $-27.92 Million | 0.00% | 0.00x | $59.18 Million |
| ABIVAX Société Anonyme (AAVXF) | $196.01 Million | -75.37% | 0.67x | $377.86 Million |
| Abcellera Biologics Inc (ABCL) | $10.25 Million | -21.57% | 1.29x | $738.02 Million |
| Abeona Therapeutics Inc (ABEO) | $489.00K | -1919.02% | 38.85x | $202.79 Million |
| Acumen Pharmaceuticals Inc (ABOS) | $188.78 Million | -22.70% | 0.04x | $108.65 Million |
| Abpro Holdings, Inc. (ABP) | $-22.46 Million | 0.00% | 0.00x | $2.00 Million |
| Absci Corp (ABSI) | $176.18 Million | -62.76% | 0.23x | $345.85 Million |